+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Whole Plasmid Sequencing Market - Global Forecast 2026-2032- Product Image
Whole Plasmid Sequencing Market - Global Forecast 2026-2032- Product Image
Sale

Whole Plasmid Sequencing Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6055275
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Whole Plasmid Sequencing Market is projected to reach USD 146.94 Million in 2026. It is expected to continue growing at a CAGR of 7.99%, reaching USD 234.13 Million by 2032.

Whole-Plasmid Sequencing: Executive Overview

Whole-plasmid sequencing determines the complete nucleotide sequence of plasmids, including backbones, inserts, regulatory elements, resistance markers, and structural changes. It supports research, biomanufacturing, synthetic biology, quality control, and microbial genetics by providing a comprehensive view that targeted checks may miss. Demand is shaped by the need for sequence-confirmed constructs, reproducible workflows, traceable documentation, and improved control of engineered biological materials.

Workflow Integration Is Reshaping Plasmid Characterization

The field is shifting from fragment-level verification toward end-to-end characterization of complete plasmid molecules. Laboratories increasingly combine long-read and short-read approaches, automated library preparation, improved assembly, and orthogonal confirmation to address repeat regions, rearrangements, mixed populations, and backbone integrity. These changes are also strengthening links between sequencing, cloning records, laboratory information systems, and regulated quality documentation. Adoption depends on accuracy, turnaround time, sample quality, ease of interpretation, and compatibility with existing laboratory processes.

Artificial Intelligence Improves Assembly, Interpretation, and Quality Review

Artificial intelligence and machine-learning methods are contributing to base calling, read correction, de novo assembly, variant detection, and automated comparison against expected plasmid designs. Their greatest practical value is reducing manual review of repetitive or complex regions while helping identify unexpected mutations, structural changes, contamination, and heterogeneous samples. Human oversight remains important because training-data limitations, platform-specific errors, and ambiguous biological context can affect conclusions. Effective implementation therefore requires validated pipelines, transparent quality metrics, secure data handling, and review procedures appropriate to the intended use.

Regional Dynamics Reflect Research Capacity and Regulatory Maturity

North America combines substantial molecular-biology infrastructure with strong activity in biotechnology, therapeutics, and academic research. Europe benefits from coordinated scientific networks and demanding quality expectations, while Asia-Pacific is supported by expanding genomics capacity, manufacturing activity, and synthetic-biology programs. Latin America is developing sequencing access through academic, agricultural, and health-related applications. The Middle East is building research and biotechnology capabilities around national innovation programs, and Africa is expanding genomic infrastructure while addressing access, skills, logistics, and data-governance constraints. Across regions, interoperability, local technical expertise, and reliable sample-to-report workflows influence practical adoption.

Economic and Security Alliances Shape Collaborative Use

ASEAN cooperation is relevant to shared research capacity, regional manufacturing, and cross-border training. BRICS members contribute diverse scientific and production capabilities, although infrastructure and regulatory practices vary. The European Union emphasizes harmonized research and quality frameworks, while the G7 supports advanced life-science ecosystems and high standards for data governance. GCC countries are investing in biotechnology and laboratory modernization, and NATO members have strong interests in biosafety, biosecurity, and resilient scientific supply chains. These groups create opportunities for shared protocols, reference materials, proficiency testing, and responsible data exchange.

Country-Level Priorities Range from Advanced Validation to Capacity Building

The United States and Canada have broad applications across biotechnology, research, and quality control. Germany, France, Italy, Spain, and the United Kingdom combine established life-science capabilities with structured laboratory and regulatory practices. China, Japan, South Korea, India, and Australia are strengthening sequencing, synthetic biology, and biomanufacturing capacity, with priorities differing across research, industrial, and public-sector settings. Brazil and Mexico are expanding use across biotechnology, agriculture, and academic laboratories, while Russia’s activity is influenced by domestic research capability, supply resilience, and access to specialized instrumentation. In every country, adoption is affected by validation requirements, skilled personnel, procurement conditions, and the ability to integrate sequencing data into auditable workflows.

Leaders Should Standardize Validation and Build Interoperable Workflows

Industry leaders should define intended-use requirements before selecting a sequencing approach, including acceptable error profiles, coverage expectations, detection limits, and reporting needs. They should validate workflows with representative plasmids containing repeats, GC extremes, mixed populations, and known structural variants. Combining complementary sequencing technologies can improve confidence for difficult constructs. Organizations should also connect sample tracking, sequence analysis, electronic records, and quality review; establish controls for contamination and data integrity; and train staff to interpret automated outputs. Partnerships with qualified laboratories and the use of shared reference materials can support consistent performance across sites.

Methodology: Evidence-Based Synthesis of Whole-Plasmid Sequencing Applications

This executive summary is based on a structured review of the whole-plasmid sequencing domain, including workflow requirements, sequencing technologies, analytical practices, research and manufacturing applications, regional conditions, and organizational adoption factors. Findings are synthesized from established scientific and technical knowledge rather than speculative market quantification. The assessment emphasizes verifiable use cases, technology capabilities, infrastructure differences, regulatory considerations, and implementation barriers. No market estimates, market shares, forecasts, or company-specific claims are included.

Whole-Plasmid Sequencing Supports Greater Confidence in Engineered Constructs

Complete plasmid characterization is becoming an important control point wherever sequence identity, structural integrity, and traceability affect research or production outcomes. Advances in sequencing platforms, analysis software, automation, and artificial intelligence are improving the practicality of comprehensive verification, but reliable adoption still depends on validation, skilled review, and strong data governance. Organizations that treat whole-plasmid sequencing as part of an integrated quality and information workflow will be better positioned to detect unexpected changes and maintain reproducible biological processes.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Whole Plasmid Sequencing Market, by Offering
7.1. Introduction
7.2. Consumables & Reagents
7.2.1. DNA Extraction Kits
7.2.2. Flow Cells & Consumables
7.2.3. Library Prep Kits
7.2.4. QC Reagents
7.3. Instruments & Platforms
7.3.1. Long-Read Sequencers
7.3.2. Short-Read Sequencers
7.4. Services
7.4.1. Bioinformatics Analysis
7.4.1.1. Annotation
7.4.1.2. QC Reporting
7.4.1.3. Variant Calling
7.4.2. Clone & Construct Validation
7.4.3. De Novo Assembly
7.4.4. GMP & Regulatory Testing
7.4.5. Sequence Verification
7.5. Software & Informatics
7.5.1. Analysis Pipelines
7.5.2. Cloud Portals
7.5.3. LIMS Integration
8. Whole Plasmid Sequencing Market, by Technology
8.1. Introduction
8.2. Nanopore Sequencing
8.3. Next-Generation Sequencing
8.4. Plasmid-EZ
8.5. Primer Walking
9. Whole Plasmid Sequencing Market, by Sample Type
9.1. Introduction
9.2. Blood
9.3. Saliva
9.4. Tissue
10. Whole Plasmid Sequencing Market, by Turnaround Time
10.1. Introduction
10.2. 2-3 Days
10.3. 4-7 Days
10.4. >1 Week
10.5. Same-Day/24 Hours
11. Whole Plasmid Sequencing Market, by Application
11.1. Introduction
11.2. CRISPR/Cas Constructs
11.3. Diagnostics & Assay Development
11.4. Gene Therapy Vector Validation
11.4.1. AAV Plasmids
11.4.2. Lentiviral Plasmids
11.4.3. Retroviral & Adenoviral Plasmids
11.5. Microbial Strain Engineering
11.6. Protein Expression & Antibody Engineering
11.7. Quality Control & Lot Release
11.8. Synthetic Biology & Circuit Design
11.9. Vaccine Development
12. Whole Plasmid Sequencing Market, by End User
12.1. Introduction
12.2. Academic Research Institutes
12.3. Biotechnology Companies
12.4. Clinical Research Organizations
12.5. Pharmaceutical Companies
13. Whole Plasmid Sequencing Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Whole Plasmid Sequencing Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Whole Plasmid Sequencing Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Agilent Technologies, Inc.
17.2. Angstrom Innovation
17.3. Avance Biosciences
17.4. Azenta Life Sciences
17.5. BaseClear B.V.
17.6. BGI Genomics Co., Ltd.
17.7. Bio-Rad Laboratories, Inc.
17.8. CD Genomics
17.9. Danaher Corporation
17.10. Element Biosciences
17.11. Eurofins Genomics LLC
17.12. F. Hoffmann-La Roche AG
17.13. GenScript Biotech Corporation
17.14. Illumina, Inc.
17.15. Integrated DNA Technologies
17.16. LGC Biosearch Technologies
17.17. Macrogen, Inc.
17.18. Microsynth AG
17.19. New England Biolabs
17.20. Novogene Co., Ltd.
17.21. Oxford Nanopore Technologies
17.22. Pacific Biosciences of California, Inc.
17.23. PackGene Biotech lnc.
17.24. Paragon Genomics, Inc.
17.25. Personalis Inc.
17.26. Plasmidsaurus Inc.
17.27. Polyplus-transfection S.A.
17.28. Psomagen, Inc.
17.29. Qiagen N.V.
17.30. Quintara Biosciences
17.31. Sartorius AG
17.32. seqWell
17.33. Synthego Corporation
17.34. Takara Bio Inc.
17.35. Thermo Fisher Scientific Inc.
17.36. Ultima Genomics
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Whole Plasmid Sequencing Market, Years Considered for the Study
FIGURE 2. Global Whole Plasmid Sequencing Market, Research Design
FIGURE 3. Global Whole Plasmid Sequencing Market, Research Framework
FIGURE 4. Global Whole Plasmid Sequencing Market, Data Triangulation
FIGURE 5. Global Whole Plasmid Sequencing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Whole Plasmid Sequencing Market Size, by Offering, 2025 vs 2032 (%)
FIGURE 7. Global Whole Plasmid Sequencing Market Size, by Offering, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Whole Plasmid Sequencing Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Whole Plasmid Sequencing Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Whole Plasmid Sequencing Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Whole Plasmid Sequencing Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Whole Plasmid Sequencing Market Size, by Turnaround Time, 2025 vs 2032 (%)
FIGURE 13. Global Whole Plasmid Sequencing Market Size, by Turnaround Time, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Whole Plasmid Sequencing Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Whole Plasmid Sequencing Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Whole Plasmid Sequencing Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Whole Plasmid Sequencing Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Whole Plasmid Sequencing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Whole Plasmid Sequencing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Whole Plasmid Sequencing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Whole Plasmid Sequencing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Whole Plasmid Sequencing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Whole Plasmid Sequencing Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Whole Plasmid Sequencing Market Segmentation & Coverage
TABLE 2. Global Whole Plasmid Sequencing Market Size, 2017-2032 (USD Million)
TABLE 3. Global Whole Plasmid Sequencing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 4. Global Consumables & Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Consumables & Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Consumables & Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global DNA Extraction Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global DNA Extraction Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global DNA Extraction Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Flow Cells & Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Flow Cells & Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Flow Cells & Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Library Prep Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Library Prep Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Library Prep Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global QC Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global QC Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global QC Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Instruments & Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Instruments & Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Instruments & Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Long-Read Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Long-Read Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Long-Read Sequencers Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Short-Read Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Short-Read Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Short-Read Sequencers Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Bioinformatics Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Bioinformatics Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Bioinformatics Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Annotation Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Annotation Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Annotation Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global QC Reporting Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global QC Reporting Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global QC Reporting Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Variant Calling Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Variant Calling Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Variant Calling Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Clone & Construct Validation Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Clone & Construct Validation Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Clone & Construct Validation Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global De Novo Assembly Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global De Novo Assembly Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global De Novo Assembly Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global GMP & Regulatory Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global GMP & Regulatory Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global GMP & Regulatory Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Sequence Verification Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Sequence Verification Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Sequence Verification Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Software & Informatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Software & Informatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Software & Informatics Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Analysis Pipelines Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Analysis Pipelines Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Analysis Pipelines Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Cloud Portals Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Cloud Portals Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Cloud Portals Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global LIMS Integration Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global LIMS Integration Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global LIMS Integration Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Whole Plasmid Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 68. Global Nanopore Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Nanopore Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Nanopore Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Next-Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Next-Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Next-Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Plasmid-EZ Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Plasmid-EZ Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Plasmid-EZ Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Primer Walking Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Primer Walking Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Primer Walking Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Whole Plasmid Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 81. Global Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Saliva Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Saliva Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Saliva Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Tissue Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Tissue Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Tissue Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Whole Plasmid Sequencing Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 91. Global 2-3 Days Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global 2-3 Days Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global 2-3 Days Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global 4-7 Days Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global 4-7 Days Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global 4-7 Days Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global >1 Week Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global >1 Week Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global >1 Week Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Same-Day/24 Hours Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Same-Day/24 Hours Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Same-Day/24 Hours Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Whole Plasmid Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 104. Global CRISPR/Cas Constructs Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global CRISPR/Cas Constructs Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global CRISPR/Cas Constructs Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Diagnostics & Assay Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Diagnostics & Assay Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Diagnostics & Assay Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Gene Therapy Vector Validation Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Gene Therapy Vector Validation Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Gene Therapy Vector Validation Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global AAV Plasmids Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global AAV Plasmids Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global AAV Plasmids Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Lentiviral Plasmids Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Lentiviral Plasmids Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Lentiviral Plasmids Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Retroviral & Adenoviral Plasmids Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Retroviral & Adenoviral Plasmids Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Retroviral & Adenoviral Plasmids Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Microbial Strain Engineering Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Microbial Strain Engineering Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Microbial Strain Engineering Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Protein Expression & Antibody Engineering Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Protein Expression & Antibody Engineering Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Protein Expression & Antibody Engineering Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Quality Control & Lot Release Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Quality Control & Lot Release Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Quality Control & Lot Release Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Synthetic Biology & Circuit Design Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Synthetic Biology & Circuit Design Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Synthetic Biology & Circuit Design Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Vaccine Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Vaccine Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Vaccine Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Whole Plasmid Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. Global Academic Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Academic Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Academic Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Global Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. Global Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. Global Clinical Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Global Clinical Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. Global Clinical Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 147. Global Pharmaceutical Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Global Pharmaceutical Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. Global Pharmaceutical Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 150. Global Whole Plasmid Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Asia-Pacific Whole Plasmid Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific Whole Plasmid Sequencing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific Whole Plasmid Sequencing Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 154. Asia-Pacific Whole Plasmid Sequencing Market Size, by Instruments & Platforms, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific Whole Plasmid Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific Whole Plasmid Sequencing Market Size, by Bioinformatics Analysis, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific Whole Plasmid Sequencing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific Whole Plasmid Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific Whole Plasmid Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific Whole Plasmid Sequencing Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific Whole Plasmid Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific Whole Plasmid Sequencing Market Size, by Gene Therapy Vector Validation, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific Whole Plasmid Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 164. North America Whole Plasmid Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 165. North America Whole Plasmid Sequencing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 166. North America Whole Plasmid Sequencing Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 167. North America Whole Plasmid Sequencing Market Size, by Instruments & Platforms, 2017-2032 (USD Million)
TABLE 168. North America Whole Plasmid Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 169. North America Whole Plasmid Sequencing Market Size, by Bioinformatics Analysis, 2017-2032 (USD Million)
TABLE 170. North America Whole Plasmid Sequencing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 171. North America Whole Plasmid Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 172. North America Whole Plasmid Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 173. North America Whole Plasmid Sequencing Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 174. North America Whole Plasmid Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 175. North America Whole Plasmid Sequencing Market Size, by Gene Therapy Vector Validation, 2017-2032 (USD Million)
TABLE 176. North America Whole Plasmid Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. Latin America Whole Plasmid Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 178. Latin America Whole Plasmid Sequencing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 179. Latin America Whole Plasmid Sequencing Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 180. Latin America Whole Plasmid Sequencing Market Size, by Instruments & Platforms, 2017-2032 (USD Million)
TABLE 181. Latin America Whole Plasmid Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 182. Latin America Whole Plasmid Sequencing Market Size, by Bioinformatics Analysis, 2017-2032 (USD Million)
TABLE 183. Latin America Whole Plasmid Sequencing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 184. Latin America Whole Plasmid Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 185. Latin America Whole Plasmid Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 186. Latin America Whole Plasmid Sequencing Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 187. Latin America Whole Plasmid Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 188. Latin America Whole Plasmid Sequencing Market Size, by Gene Therapy Vector Validation, 2017-2032 (USD Million)
TABLE 189. Latin America Whole Plasmid Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. Europe Whole Plasmid Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 191. Europe Whole Plasmid Sequencing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 192. Europe Whole Plasmid Sequencing Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 193. Europe Whole Plasmid Sequencing Market Size, by Instruments & Platforms, 2017-2032 (USD Million)
TABLE 194. Europe Whole Plasmid Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 195. Europe Whole Plasmid Sequencing Market Size, by Bioinformatics Analysis, 2017-2032 (USD Million)
TABLE 196. Europe Whole Plasmid Sequencing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 197. Europe Whole Plasmid Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 198. Europe Whole Plasmid Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 199. Europe Whole Plasmid Sequencing Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 200. Europe Whole Plasmid Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. Europe Whole Plasmid Sequencing Market Size, by Gene Therapy Vector Validation, 2017-2032 (USD Million)
TABLE 202. Europe Whole Plasmid Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 203. Middle East Whole Plasmid Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 204. Middle East Whole Plasmid Sequencing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 205. Middle East Whole Plasmid Sequencing Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 206. Middle East Whole Plasmid Sequencing Market Size, by Instruments & Platforms, 2017-2032 (USD Million)
TABLE 207. Middle East Whole Plasmid Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 208. Middle East Whole Plasmid Sequencing Market Size, by Bioinformatics Analysis, 2017-2032 (USD Million)
TABLE 209. Middle East Whole Plasmid Sequencing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 210. Middle East Whole Plasmid Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 211. Middle East Whole Plasmid Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 212. Middle East Whole Plasmid Sequencing Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 213. Middle East Whole Plasmid Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 214. Middle East Whole Plasmid Sequencing Market Size, by Gene Therapy Vector Validation, 2017-2032 (USD Million)
TABLE 215. Middle East Whole Plasmid Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. Africa Whole Plasmid Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 217. Africa Whole Plasmid Sequencing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 218. Africa Whole Plasmid Sequencing Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 219. Africa Whole Plasmid Sequencing Market Size, by Instruments & Platforms, 2017-2032 (USD Million)
TABLE 220. Africa Whole Plasmid Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 221. Africa Whole Plasmid Sequencing Market Size, by Bioinformatics Analysis, 2017-2032 (USD Million)
TABLE 222. Africa Whole Plasmid Sequencing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 223. Africa Whole Plasmid Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 224. Africa Whole Plasmid Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 225. Africa Whole Plasmid Sequencing Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 226. Africa Whole Plasmid Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. Africa Whole Plasmid Sequencing Market Size, by Gene Therapy Vector Validation, 2017-2032 (USD Million)
TABLE 228. Africa Whole Plasmid Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. Global Whole Plasmid Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 230. ASEAN Whole Plasmid Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 231. ASEAN Whole Plasmid Sequencing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 232. ASEAN Whole Plasmid Sequencing Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 233. ASEAN Whole Plasmid Sequencing Market Size, by Instruments & Platforms, 2017-2032 (USD Million)
TABLE 234. ASEAN Whole Plasmid Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 235. ASEAN Whole Plasmid Sequencing Market Size, by Bioinformatics Analysis, 2017-2032 (USD Million)
TABLE 236. ASEAN Whole Plasmid Sequencing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 237. ASEAN Whole Plasmid Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 238. ASEAN Whole Plasmid Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 239. ASEAN Whole Plasmid Sequencing Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 240. ASEAN Whole Plasmid Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. ASEAN Whole Plasmid Sequencing Market Size, by Gene Therapy Vector Validation, 2017-2032 (USD Million)
TABLE 242. ASEAN Whole Plasmid Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. GCC Whole Plasmid Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 244. GCC Whole Plasmid Sequencing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 245. GCC Whole Plasmid Sequencing Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 246. GCC Whole Plasmid Sequencing Market Size, by Instruments & Platforms, 2017-2032 (USD Million)
TABLE 247. GCC Whole Plasmid Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 248. GCC Whole Plasmid Sequencing Market Size, by Bioinformatics Analysis, 2017-2032 (USD Million)
TABLE 249. GCC Whole Plasmid Sequencing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 250. GCC Whole Plasmid Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 251. GCC Whole Plasmid Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 252. GCC Whole Plasmid Sequencing Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 253. GCC Whole Plasmid Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. GCC Whole Plasmid Sequencing Market Size, by Gene Therapy Vector Validation, 2017-2032 (USD Million)
TABLE 255. GCC Whole Plasmid Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. European Union Whole Plasmid Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 257. European Union Whole Plasmid Sequencing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 258. European Union Whole Plasmid Sequencing Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 259. European Union Whole Plasmid Sequencing Market Size, by Instruments & Platforms, 2017-2032 (USD Million)
TABLE 260. European Union Whole Plasmid Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 261. European Union Whole Plasmid Sequencing Market Size, by Bioinformatics Analysis, 2017-2032 (USD Million)
TABLE 262. European Union Whole Plasmid Sequencing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 263. European Union Whole Plasmid Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 264. European Union Whole Plasmid Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 265. European Union Whole Plasmid Sequencing Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 266. European Union Whole Plasmid Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 267. European Union Whole Plasmid Sequencing Market Size, by Gene Therapy Vector Validation, 2017-2032 (USD Million)
TABLE 268. European Union Whole Plasmid Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. BRICS Whole Plasmid Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 270. BRICS Whole Plasmid Sequencing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 271. BRICS Whole Plasmid Sequencing Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 272. BRICS Whole Plasmid Sequencing Market Size, by Instruments & Platforms, 2017-2032 (USD Million)
TABLE 273. BRICS Whole Plasmid Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 274. BRICS Whole Plasmid Sequencing Market Size, by Bioinformatics Analysis, 2017-2032 (USD Million)
TABLE 275. BRICS Whole Plasmid Sequencing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 276. BRICS Whole Plasmid Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 277. BRICS Whole Plasmid Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 278. BRICS Whole Plasmid Sequencing Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 279. BRICS Whole Plasmid Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 280. BRICS Whole Plasmid Sequencing Market Size, by Gene Therapy Vector Validation, 2017-2032 (USD Million)
TABLE 281. BRICS Whole Plasmid Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 282. G7 Whole Plasmid Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 283. G7 Whole Plasmid Sequencing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 284. G7 Whole Plasmid Sequencing Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 285. G7 Whole Plasmid Sequencing Market Size, by Instruments & Platforms, 2017-2032 (USD Million)
TABLE 286. G7 Whole Plasmid Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 287. G7 Whole Plasmid Sequencing Market Size, by Bioinformatics Analysis, 2017-2032 (USD Million)
TABLE 288. G7 Whole Plasmid Sequencing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 289. G7 Whole Plasmid Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 290. G7 Whole Plasmid Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 291. G7 Whole Plasmid Sequencing Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 292. G7 Whole Plasmid Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 293. G7 Whole Plasmid Sequencing Market Size, by Gene Therapy Vector Validation, 2017-2032 (USD Million)
TABLE 294. G7 Whole Plasmid Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 295. NATO Whole Plasmid Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 296. NATO Whole Plasmid Sequencing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 297. NATO Whole Plasmid Sequencing Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 298. NATO Whole Plasmid Sequencing Market Size, by Instruments & Platforms, 2017-2032 (USD Million)
TABLE 299. NATO Whole Plasmid Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 300. NATO Whole Plasmid Sequencing Market Size, by Bioinformatics Analysis, 2017-2032 (USD Million)
TABLE 301. NATO Whole Plasmid Sequencing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 302. NATO Whole Plasmid Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 303. NATO Whole Plasmid Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 304. NATO Whole Plasmid Sequencing Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 305. NATO Whole Plasmid Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 306. NATO Whole Plasmid Sequencing Market Size, by Gene Therapy Vector Validation, 2017-2032 (USD Million)
TABLE 307. NATO Whole Plasmid Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 308. Global Whole Plasmid Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 309. United States Whole Plasmid Sequencing Market Size, 2017-2032 (USD Million)
TABLE 310. United States Whole Plasmid Sequencing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 311. United States Whole Plasmid Sequencing Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 312. United States Whole Plasmid Sequencing Market Size, by Instruments & Platforms, 2017-2032 (USD Million)
TABLE 313. United States Whole Plasmid Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 314. United States Whole Plasmid Sequencing Market Size, by Bioinformatics Analysis, 2017-2032 (USD Million)
TABLE 315. United States Whole Plasmid Sequencing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 316. United States Whole Plasmid Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 317. United States Whole Plasmid Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 318. United States Whole Plasmid Sequencing Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 319. United States Whole Plasmid Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 320. United States Whole Plasmid Sequencing Market Size, by Gene Therapy Vector Validation, 2017-2032 (USD Million)
TABLE 321. United States Whole Plasmid Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 322. Canada Whole Plasmid Sequencing Market Size, 2017-2032 (USD Million)
TABLE 323. Canada Whole Plasmid Sequencing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 324. Canada Whole Plasmid Sequencing Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 325. Canada Whole Plasmid Sequencing Market Size, by Instruments & Platforms, 2017-2032 (USD Million)
TABLE 326. Canada Whole Plasmid Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 327. Canada Whole Plasmid Sequencing Market Size, by Bioinformatics Analysis, 2017-2032 (USD Million)
TABLE 328. Canada Whole Plasmid Sequencing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 329. Canada Whole Plasmid Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 330. Canada Whole Plasmid Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 331. Canada Whole Plasmid Sequencing Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 332. Canada Whole Plasmid Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 333. Canada Whole Plasmid Sequencing Market Size, by Gene Therapy Vector Validation, 2017-2032 (USD Million)
TABLE 334. Canada Whole Plasmid Sequencing Market Size, by End User, 2017-2032 (USD Million)
TABLE 335. Mexico Whole Plasmid Sequencing Market Size, 2017-2032 (USD Million)
TABLE 336. Mexico Whole Plasmid Sequencing Market Size, by Offering, 2017-2032 (USD Million)
TABLE 337. Mexico Whole Plasmid Sequencing Market Size, by Consumables & Reagents, 2017-2032 (USD Million)
TABLE 338. Mexico Whole Plasmid Sequencing Market Size, by Instruments & Platforms, 2017-2032 (USD Million)
TABLE 339. Mexico Whole Plasmid Sequencing Market Size, by Services, 2017-2032 (USD Million)
TABLE 340. Mexico Whole Plasmid Sequencing Market Size, by Bioinformatics Analysis, 2017-2032 (USD Million)
TABLE 341. Mexico Whole Plasmid Sequencing Market Size, by Software & Informatics, 2017-2032 (USD Million)
TABLE 342. Mexico Whole Plasmid Sequencing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 343. Mexico Whole Plasmid Sequencing Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 344. Mexico Whole Plasmid Sequencing Market Size, by Turnaround Time, 2017-2032 (USD Million)
TABLE 345. Mexico Whole Plasmid Sequencing Market Size, by Application, 2017-2032 (USD Million)
TABLE 346. Mexico Whole Plasmid S

Companies Mentioned

  • Agilent Technologies, Inc.
  • Angstrom Innovation
  • Avance Biosciences
  • Azenta Life Sciences
  • BaseClear B.V.
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • CD Genomics
  • Danaher Corporation
  • Element Biosciences
  • Eurofins Genomics LLC
  • F. Hoffmann-La Roche AG
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • Integrated DNA Technologies
  • LGC Biosearch Technologies
  • Macrogen, Inc.
  • Microsynth AG
  • New England Biolabs
  • Novogene Co., Ltd.
  • Oxford Nanopore Technologies
  • Pacific Biosciences of California, Inc.
  • PackGene Biotech lnc.
  • Paragon Genomics, Inc.
  • Personalis Inc.
  • Plasmidsaurus Inc.
  • Polyplus-transfection S.A.
  • Psomagen, Inc.
  • Qiagen N.V.
  • Quintara Biosciences
  • Sartorius AG
  • seqWell
  • Synthego Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Ultima Genomics

Related Topics

Related Reports

Plasmid Purification Kits Market - Global Forecast 2026-2032 - Product Image

Plasmid Purification Kits Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Research Grade Plasmid DNA Manufacturing Market - Global Forecast 2026-2032 - Product Image

Research Grade Plasmid DNA Manufacturing Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Plasmid Purification Market Outlook 2026-2034: Market Share, and Growth Analysis by Product (& Services Type, Kits & Reagents, Instruments & Systems, Consumables, Purification Services), Purity Grade, Application, End User - Product Image

Plasmid Purification Market Outlook 2026-2034: Market Share, and Growth Analysis by Product (& Services Type, Kits & Reagents, Instruments & Systems, Consumables, Purification Services), Purity Grade, Application, End User

  • Report
  • 160 Pages
  • Global
From
Viral Vector and Plasmid DNA Manufacturing Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type (Plasmid DNA, Viral Vector, Non-Viral Vector), Application - Product Image

Viral Vector and Plasmid DNA Manufacturing Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type (Plasmid DNA, Viral Vector, Non-Viral Vector), Application

  • Report
  • 160 Pages
  • Global
From
Plasmid Service Market Report: Trends, Forecast and Competitive Analysis to 2035 - Product Image

Plasmid Service Market Report: Trends, Forecast and Competitive Analysis to 2035

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.